Alzheimer’s Association should see healthy amount of proposed $401 million funding increase
The Alzheimer’s Association, its advocacy arm the Alzheimer’s Impact Movement and its nationwide network of advocates are celebrating another proposed funding increase for Alzheimer’s and dementia research at the National Institutes of Health, according to the Athens Daily Review.
The House Appropriations Labor, Health and Human Services, Education and Related Agencies Subcommittee has included a $401 million increase for fiscal year 2019.
“We commend the subcommittee and Congressman Cole (R-Okla.) for their bipartisan effort to secure another significant increase,” said Harry Johns, Alzheimer’s Association and AIM president and CEO, in a press release. “Alzheimer’s is the only leading cause of death in the U.S. that cannot be prevented, cured or even slowed. But through medical breakthroughs, we’re working together to change that.”
Recent years of historic funding increases have enabled scientists across the country to explore new areas of research. Because of the increased investment by the NIH, researchers are advancing the understanding of the disease, exploring biomarkers, discovering potential ways to reduce risk, and are working to move promising therapeutic candidates and diagnostic tools forward into clinical testing.
This increase would provide the NIH the resources needed to stay on track to reach the National Alzheimer’s Plan goal to prevent and effectively treat Alzheimer’s disease by 2025.
Read the full story at the Athens Daily Review.
I Advance Senior Care is the industry-leading source for practical, in-depth, business-building, and resident care information for owners, executives, administrators, and directors of nursing at assisted living communities, skilled nursing facilities, post-acute facilities, and continuing care retirement communities. I Advance Senior Care editorial team and industry experts provide market analysis, strategic direction, policy commentary, clinical best-practices, business management, and technology breakthroughs.
Topics: Alzheimer's/Dementia , Finance , Uncategorized